• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无创产前检测(NIPT)的范围是否应该受到“严重程度阈值”的限制?

Should the scope of NIPT be limited by a 'threshold of seriousness'?

作者信息

Taylor-Sands Michelle, Johnston Molly, Mills Catherine

机构信息

Melbourne Law School, The University of Melbourne, Parkville, VIC, Australia.

Murdoch Children's Research Institute, Parkville, VIC, Australia.

出版信息

Eur J Hum Genet. 2025 Mar;33(2):189-193. doi: 10.1038/s41431-024-01684-x. Epub 2024 Aug 16.

DOI:10.1038/s41431-024-01684-x
PMID:39152297
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11839980/
Abstract

Non-invasive prenatal testing (NIPT) has the potential to screen for a wider range of genetic conditions than is currently possible at an early stage of pregnancy and with minimal risks. As such, there have been calls to apply a 'threshold of seriousness' to limit the scope of conditions being tested. This approach is based on concerns about society at large and the potential impact on specific groups within it. In this paper, we argue that limiting the scope of NIPT using the criterion of 'seriousness' is arbitrary, potentially stigmatises certain disabilities over others and fails to respect reproductive autonomy. We contend that concerns about expanded NIPT are more appropriately addressed by the provision of adequate information, counselling and consent procedures. We recommend a decision-making process that helps healthcare providers support prospective parents to make informed decisions about the nature and scope of NIPT screening based on their own values and social context. In addition to addressing concerns about expanded NIPT screening, this process would help clinicians to obtain legally valid consent and discharge their duty of care (including the duty to inform) in the prenatal context.

摘要

无创产前检测(NIPT)有潜力在怀孕早期筛查比目前范围更广的遗传疾病,且风险极小。因此,有人呼吁应用“严重性阈值”来限制检测疾病的范围。这种方法基于对整个社会以及其中特定群体可能产生的影响的担忧。在本文中,我们认为,使用“严重性”标准来限制NIPT的范围是武断的,可能会使某些残疾比其他残疾更受歧视,并且未能尊重生殖自主权。我们认为,通过提供充分的信息、咨询和同意程序,可以更妥善地解决对NIPT范围扩大的担忧。我们建议采用一种决策过程,帮助医疗保健提供者支持准父母根据他们自己的价值观和社会背景,就NIPT筛查的性质和范围做出明智的决定。除了解决对NIPT筛查范围扩大的担忧之外,这一过程将有助于临床医生获得具有法律效力的同意,并在产前环境中履行他们的护理职责(包括告知义务)。

相似文献

1
Should the scope of NIPT be limited by a 'threshold of seriousness'?无创产前检测(NIPT)的范围是否应该受到“严重程度阈值”的限制?
Eur J Hum Genet. 2025 Mar;33(2):189-193. doi: 10.1038/s41431-024-01684-x. Epub 2024 Aug 16.
2
Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals.非侵入性产前检测(NIPT)的范围限制:对产前筛查国际伦理框架的分析及对荷兰专业人士的访谈研究。
BMC Pregnancy Childbirth. 2018 Oct 19;18(1):409. doi: 10.1186/s12884-018-2050-4.
3
Cross-cultural perspectives on decision making regarding noninvasive prenatal testing: A comparative study of Lebanon and Quebec.关于无创产前检测决策的跨文化视角:黎巴嫩和魁北克的比较研究。
AJOB Empir Bioeth. 2018 Apr-Jun;9(2):99-111. doi: 10.1080/23294515.2018.1469551.
4
Reproductive deliberation: Supporting autonomous decision making in prenatal genetic counseling.生殖决策:支持产前遗传咨询中的自主决策。
J Genet Couns. 2023 Jun;32(3):576-583. doi: 10.1002/jgc4.1682. Epub 2023 Feb 10.
5
Rethinking counselling in prenatal screening: An ethical analysis of informed consent in the context of non-invasive prenatal testing (NIPT).反思产前筛查中的咨询:非侵入性产前检测(NIPT)背景下知情同意的伦理分析。
Bioethics. 2020 Sep;34(7):671-678. doi: 10.1111/bioe.12760. Epub 2020 Jul 4.
6
Ethics of routine: a critical analysis of the concept of 'routinisation' in prenatal screening.常规伦理:对产前筛查中“常规化”概念的批判性分析。
J Med Ethics. 2018 Sep;44(9):626-631. doi: 10.1136/medethics-2017-104729. Epub 2018 Apr 25.
7
Prenatal screening: current practice, new developments, ethical challenges.产前筛查:当前实践、新进展与伦理挑战
Bioethics. 2015 Jan;29(1):1-8. doi: 10.1111/bioe.12123.
8
Pandora's pregnancy: NIPT, CMA, and genome sequencing-A new era for prenatal genetic testing.潘多拉的孕事:NIPT、CMA 和全基因组测序——产前基因检测的新纪元。
Prenat Diagn. 2019 Sep;39(10):859-865. doi: 10.1002/pd.5495. Epub 2019 Jun 25.
9
A qualitative study of women and partners from Lebanon and Quebec regarding an expanded scope of noninvasive prenatal testing.黎巴嫩和魁北克的女性及其伴侣对扩大无创性产前检测范围的定性研究。
BMC Pregnancy Childbirth. 2021 Jan 13;21(1):54. doi: 10.1186/s12884-020-03538-y.
10
Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social Issues.无创产前基因检测:当前及新出现的伦理、法律和社会问题。
Annu Rev Genomics Hum Genet. 2015;16:369-98. doi: 10.1146/annurev-genom-090314-050000.

引用本文的文献

1
Editorial: severity in a genomic age.社论:基因组时代的严重性
Eur J Hum Genet. 2025 Mar;33(2):144-146. doi: 10.1038/s41431-024-01766-w. Epub 2025 Feb 19.

本文引用的文献

1
Disparities in integrating non-invasive prenatal testing into antenatal healthcare in Australia: a survey of healthcare professionals.澳大利亚将无创产前检测纳入产前保健中的差异:对医疗保健专业人员的调查。
BMC Pregnancy Childbirth. 2024 May 14;24(1):355. doi: 10.1186/s12884-024-06565-1.
2
Evaluation of pre-test counselling offered for non-invasive prenatal testing (NIPT) as a primary screening tool.评估作为主要筛查工具的无创产前检测(NIPT)的检测前咨询服务。
J Obstet Gynaecol. 2023 Dec;43(1):2204959. doi: 10.1080/01443615.2023.2204959.
3
Position statement from the International Society for Prenatal Diagnosis on the use of non-invasive prenatal testing for the detection of fetal chromosomal conditions in singleton pregnancies.国际产前诊断学会关于在单胎妊娠中使用无创产前检测来检测胎儿染色体疾病的立场声明。
Prenat Diagn. 2023 Jun;43(7):814-828. doi: 10.1002/pd.6357. Epub 2023 May 16.
4
Reproductive deliberation: Supporting autonomous decision making in prenatal genetic counseling.生殖决策:支持产前遗传咨询中的自主决策。
J Genet Couns. 2023 Jun;32(3):576-583. doi: 10.1002/jgc4.1682. Epub 2023 Feb 10.
5
How should severity be understood in the context of reproductive genetic carrier screening?在生殖遗传携带者筛查的背景下,应如何理解严重程度?
Bioethics. 2023 May;37(4):359-366. doi: 10.1111/bioe.13136. Epub 2023 Feb 6.
6
Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).一般风险人群胎儿染色体异常的无创产前筛查(NIPS):美国医学遗传学与基因组学学会(ACMG)基于证据的临床指南。
Genet Med. 2023 Feb;25(2):100336. doi: 10.1016/j.gim.2022.11.004. Epub 2022 Dec 16.
7
Clinician views and experiences of non-invasive prenatal genetic screening tests in Australia.澳大利亚临床医生对无创性产前基因筛查检测的看法和经验。
Aust N Z J Obstet Gynaecol. 2022 Dec;62(6):830-837. doi: 10.1111/ajo.13533. Epub 2022 May 10.
8
Moving from 'fully' to 'appropriately' informed consent in genomics: The PROMICE framework.从“完全”知情同意到“适当”知情同意在基因组学中的转变:PROMICE 框架。
Bioethics. 2022 Jul;36(6):655-665. doi: 10.1111/bioe.13027. Epub 2022 Apr 7.
9
NIPT and the concerns regarding 'routinisation'.无创产前检测(NIPT)与对“常规化”的担忧。
Eur J Hum Genet. 2022 Jun;30(6):637-638. doi: 10.1038/s41431-022-01053-6. Epub 2022 Feb 7.
10
Expanded Prenatal Testing: Maintaining a Non-Directive Approach to Promote Reproductive Autonomy.扩大产前检测:保持非指导性方法以促进生殖自主权。
Am J Bioeth. 2022 Feb;22(2):39-42. doi: 10.1080/15265161.2021.2013988.